Research ArticleArticle
Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus
Lucy H. Liu, Helene B. Fevrier, Robert Goldfien, Anke Hemmerling and Lisa J. Herrinton
The Journal of Rheumatology February 2019, jrheum.180946; DOI: https://doi.org/10.3899/jrheum.180946
Lucy H. Liu
From the Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland; Department of Medicine, Division of Rheumatology, University of California, San Francisco; Division of Research, and Department of Rheumatology, Kaiser Permanente Northern California, Oakland; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco, San Francisco, California, USA. L.H. Liu, MD, MPH, Department of Medicine, Kaiser Permanente Oakland Medical Center, and Department of Medicine, Division of Rheumatology, University of California, San Francisco; H.B. Fevrier, MSPH, MS, Division of Research, Kaiser Permanente Northern California; R. Goldfien, MD, Department of Rheumatology, Kaiser Permanente Northern California; A. Hemmerling, MD, PhD, MPH, Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco; L.J. Herrinton, PhD, Division of Research, Kaiser Permanente Northern California. Address correspondence to L.J. Herrinton, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, California 94612, USA. E-mail: Lisa.Herrinton@kp.org. Accepted for publication January 10, 2019.
Helene B. Fevrier
From the Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland; Department of Medicine, Division of Rheumatology, University of California, San Francisco; Division of Research, and Department of Rheumatology, Kaiser Permanente Northern California, Oakland; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco, San Francisco, California, USA. L.H. Liu, MD, MPH, Department of Medicine, Kaiser Permanente Oakland Medical Center, and Department of Medicine, Division of Rheumatology, University of California, San Francisco; H.B. Fevrier, MSPH, MS, Division of Research, Kaiser Permanente Northern California; R. Goldfien, MD, Department of Rheumatology, Kaiser Permanente Northern California; A. Hemmerling, MD, PhD, MPH, Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco; L.J. Herrinton, PhD, Division of Research, Kaiser Permanente Northern California. Address correspondence to L.J. Herrinton, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, California 94612, USA. E-mail: Lisa.Herrinton@kp.org. Accepted for publication January 10, 2019.
Robert Goldfien
From the Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland; Department of Medicine, Division of Rheumatology, University of California, San Francisco; Division of Research, and Department of Rheumatology, Kaiser Permanente Northern California, Oakland; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco, San Francisco, California, USA. L.H. Liu, MD, MPH, Department of Medicine, Kaiser Permanente Oakland Medical Center, and Department of Medicine, Division of Rheumatology, University of California, San Francisco; H.B. Fevrier, MSPH, MS, Division of Research, Kaiser Permanente Northern California; R. Goldfien, MD, Department of Rheumatology, Kaiser Permanente Northern California; A. Hemmerling, MD, PhD, MPH, Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco; L.J. Herrinton, PhD, Division of Research, Kaiser Permanente Northern California. Address correspondence to L.J. Herrinton, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, California 94612, USA. E-mail: Lisa.Herrinton@kp.org. Accepted for publication January 10, 2019.
Anke Hemmerling
From the Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland; Department of Medicine, Division of Rheumatology, University of California, San Francisco; Division of Research, and Department of Rheumatology, Kaiser Permanente Northern California, Oakland; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco, San Francisco, California, USA. L.H. Liu, MD, MPH, Department of Medicine, Kaiser Permanente Oakland Medical Center, and Department of Medicine, Division of Rheumatology, University of California, San Francisco; H.B. Fevrier, MSPH, MS, Division of Research, Kaiser Permanente Northern California; R. Goldfien, MD, Department of Rheumatology, Kaiser Permanente Northern California; A. Hemmerling, MD, PhD, MPH, Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco; L.J. Herrinton, PhD, Division of Research, Kaiser Permanente Northern California. Address correspondence to L.J. Herrinton, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, California 94612, USA. E-mail: Lisa.Herrinton@kp.org. Accepted for publication January 10, 2019.
Lisa J. Herrinton
From the Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland; Department of Medicine, Division of Rheumatology, University of California, San Francisco; Division of Research, and Department of Rheumatology, Kaiser Permanente Northern California, Oakland; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco, San Francisco, California, USA. L.H. Liu, MD, MPH, Department of Medicine, Kaiser Permanente Oakland Medical Center, and Department of Medicine, Division of Rheumatology, University of California, San Francisco; H.B. Fevrier, MSPH, MS, Division of Research, Kaiser Permanente Northern California; R. Goldfien, MD, Department of Rheumatology, Kaiser Permanente Northern California; A. Hemmerling, MD, PhD, MPH, Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco; L.J. Herrinton, PhD, Division of Research, Kaiser Permanente Northern California. Address correspondence to L.J. Herrinton, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, California 94612, USA. E-mail: Lisa.Herrinton@kp.org. Accepted for publication January 10, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Understanding Nonadherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus
Lucy H. Liu, Helene B. Fevrier, Robert Goldfien, Anke Hemmerling, Lisa J. Herrinton
The Journal of Rheumatology Feb 2019, jrheum.180946; DOI: 10.3899/jrheum.180946